Randomised open-label trial of insulin lispro protamin suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients

被引：0
|
作者：
Giugliano, D.
Cleall, S.
Pontiroli, A. E.
Koivisto, V.
机构：
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1037
引用
收藏
页码：S421 / S422
页数：2
相关论文
共 50 条
  • [1] Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial
    Koivisto, V.
    Cleall, S.
    Pontiroli, A. E.
    Giugliano, D.
    DIABETES OBESITY & METABOLISM, 2011, 13 (12): : 1149 - 1157
  • [2] Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial
    Jia, Weiping
    Xiao, Xinhua
    Ji, Qiuhe
    Ahn, Kyu-Jeung
    Chuang, Lee-Ming
    Bao, Yuqian
    Pang, Can
    Chen, Lei
    Gao, Fei
    Tu, Yinfang
    Li, Pengfei
    Yang, Jun
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (04): : 254 - 262
  • [3] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial
    Tinahones, F. J.
    Gross, J. L.
    Onaca, A.
    Cleall, S.
    Rodriguez, A.
    DIABETES OBESITY & METABOLISM, 2014, 16 (10): : 963 - 970
  • [4] Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a prospective randomized open-label trial
    Arakaki, R. F.
    Blevins, T. C.
    Wise, J. K.
    Liljenquist, D. R.
    Jiang, H. H.
    Jacobson, J. G.
    Martin, S. A.
    Jackson, J. A.
    DIABETES OBESITY & METABOLISM, 2014, 16 (06): : 510 - 518
  • [5] A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
    Riccardo Candido
    Kathleen Wyne
    Ester Romoli
    Diabetes Therapy, 2018, 9 : 927 - 949
  • [6] Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes
    Chacra, A. R.
    Kipnes, M.
    Ilag, L. L.
    Sarwat, S.
    Giaconia, J.
    Chan, J.
    DIABETIC MEDICINE, 2010, 27 (05) : 563 - 569
  • [7] A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
    Candido, Riccardo
    Wyne, Kathleen
    Romoli, Ester
    DIABETES THERAPY, 2018, 9 (03) : 927 - 949
  • [8] Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents - Prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy
    Rosenstock, Julio
    Scism-Bacon, Jamie
    Ahmann, Andrew J.
    Jiang, Honghua
    Colon, Gildred
    Martin, Sherry
    DIABETES CARE, 2008, 31 (01) : 20 - 25
  • [9] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes mellitus requiring insulin intensification—a randomized phase IV trial: Indian subpopulation analyses
    K. M. Prasanna Kumar
    Sanjiv Shah
    Parag Shah
    Simon Cleall
    Steve Chen
    Shweta Uppal
    International Journal of Diabetes in Developing Countries, 2017, 37 : 116 - 123
  • [10] Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial
    Arturo Rojas
    Georgina Sposetti
    Jorge L. Gross
    Douglas Eugenio Barbieri
    Ran Duan
    Bruno Linetzky
    Janaina Martins De Lana
    Oded Stempa
    Angel Rodriguez
    Diabetology & Metabolic Syndrome, 8
12345